Chromoblastomycosis and disseminated superficial porokeratosis with secondary cutaneous amyloidosis: a case report

Authors

  • Sakchai Chaiyamahapurk Faculty of Medicine, Naresuan University, Phitsanulok
  • Chaiyaporn Virochsangaroon Faculty of Medicine, Naresuan University, Phitsanulok
  • Prateep Warnnisorn Faculty of Medicine, Naresuan University, Phitsanulok

Keywords:

Chromoblastomycosis, Itraconazole, Porokeratosis, Amyloidosis

Abstract

Chromoblastomycosis is an uncommon skin disease which could lead to delay diagnosis and disfiguring lesion. The patient has verrucous lesion with black dots, KOH finding of sclerotic bodies and mixed cell granulomatous inflammation from tissue section help confirm diagnosis. Disseminated superficial porokeratosis is a rare skin disease with the presence multiple scattered macules and papules on body and extremities. The characteristics are annular ridge at the rim of lesion and cornoid lamella and the presence of parakeratotic column in histopathological study. We report a co-existence of chromoblastomycosis and disseminated superficial porokeratosis with secondary cutaneous amyloidosis in a 70 year old male patient.

References

1. Kauffman CL, Hamet VH, Tahan SR, Busam KJ, Barnhill RL. Fungal infections. In: Barnhill RL, Crowson AN, Magro CN, Piepkorn MW, editors. Dermatopathology. 3rd ed. New York:McGraw-Hill Education; 2010:475-477.

2. Global Action Fund for Fungal Infections. Proposal for WHO STAG adoption as an NTD Chromoblastomycosis-a true tropical neglected tropical disease access [cited 2018 April 15]. Available from http://www.blackyeast.org/ Literature/ Literatur/Chromoblastomycosis-WHOproposal.pdf.

3. Kampirapap K, Reangchainam S, Ornpaew P,Tresukosol P. Chromoblastomycosis masquerading as dermatophytosis, with the description of a new opportunistic species. Southeast Asian J Trop Med Public Health. 2015; 46:105-9.

4. Ungpakorn R. Mycoses in Thailand: Current Concerns. Nihon Ishinkin Gakkai Zasshi. 2005; 46; 81-86.

5. Mahaisavariya P, Chaiprasert A, Sivayathorn A, Khemnger S. Deep fungal and higher bacterial skin infections in Thailand: clinical manifestations and treatment regimens. Int J Dermatol. 1999; 38:279–284.

6. Elewski BE, Hughey LC, Sobera JO, Hay R. Fungal disease. In: Bolognia JL,Schaffer JV, Cerroni L, editors. Dermatology.3th ed.Elsevier;2012.1267- 70.

7. Esterrea P, Queiroz-Telles F. Management of chromoblastomycosis: novel perspectives. Curr Opin Infect Dis. 2006, 19:148–152.

8. William DJ,Elston D, Berger T,Neuhaus I. Andrews' Diseases of the Skin: Clinical Dermatology. 11th ed. Elsevier;2011:313-314.

9. Carlessimo M, Rossi A, fidanza L, et al. Disseminate superficial porokeratosis with dermal amyloid deposit. Case Rep Dermatol. 2009;1:35- 38.

10. Kim Jh, Yim H, Kang WH. Secondary cutaneous amyloidosis in disseminated superficial porokeratosis. A case report. J Korean Med Sci. 2000; 15:478-81.

11. Piamphongsant T, Sittapairodchana D. Localized cutaneous amyloidosis in disseminated superficial actinic porokeratosis. J Cut Patho. 1974; 1: 207-21.

12. Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Bonifaz A. Chromoblastomycosis: an overview of clinical manifestation, diagnosis and treatment. Med Mycol. 2009; 47: 3–15.

13. Skupsky H, Junkins-Hopkins J. Counterfeit Pennies: Distinguishing Chromoblastomycosis from Phaeohyphomycotic Infections. Am J Dermatopathol. 2017;39:485-487.

Downloads

Published

2018-12-05

How to Cite

Chaiyamahapurk, S., Virochsangaroon, C., & Warnnisorn, P. (2018). Chromoblastomycosis and disseminated superficial porokeratosis with secondary cutaneous amyloidosis: a case report. Thai Journal of Dermatology, 34(2), 169–175. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/159065

Issue

Vol. 34 No. 2 (2018): April - June

Section

Case Report

License

เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสาร ไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใดๆ

บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นลิขสิทธิ์ของวารสารฯ หากบุคคลหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใดๆ จะต้องได้รับอนุญาตเป็นลายลักอักษรจากบรรณาธิการวารสารโรคผิวหนังก่อนเท่านั้น